MAPK pathway activation selectively inhibits ASCL1-driven small cell lung cancer

MAPK pathway activation selectively inhibits ASCL1-driven small cell lung cancer

Summary: Activation of mitogenic signaling pathways is a common oncogenic driver of many solid tumors including lung cancer. Although activating mutations in the mitogen-activated protein kinase (MAPK) pathway are prevalent in non-small cell lung cancers, MAPK pathway activity, counterintuitively, i...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Rebecca Caeser, Christopher Hulton, Emily Costa, Vidushi Durani, Megan Little, Xiaoping Chen, Sam E. Tischfield, Marina Asher, Faruk Erdem Kombak, Shweta S. Chavan, Nisargbhai S. Shah, Metamia Ciampricotti, Elisa de Stanchina, John T. Poirier, Charles M. Rudin, Triparna Sen
Format: article
Langue:EN
Publié: Elsevier 2021
Sujets:
Biological sciences
Cell biology
Molecular biology
Science
Q
Accès en ligne:https://doaj.org/article/408084487e324b9abf64eba52e8ffc2a
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/408084487e324b9abf64eba52e8ffc2a

Documents similaires